USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NANOTRANS TECHNOLOGIES, INC.
City: NEW YORK
State: NY
Zip+4: 10128-0781
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $271,468.00 1

Award List:

Topical Nanoparticles for CNV

Award Year / Program / Phase: 2010 / STTR / Phase I
Agency: HHS
Research Institution: University Of Colorado Denver/Hsc Denver
Principal Investigator: Uday B. Kompella – 303-724-4028
Award Amount: $271,468.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Age Related Macular Degeneration (AMD) is the leading cause of blindness in adults over 50 years. Choroidal neovascularization (CNV), the pathologic creation of new blood vessels in the choroid layer of the eye, is a principal cause of blindness due to AMD.… More